We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Digital Quality Control Tool Identifies Cells in Blood

By LabMedica International staff writers
Posted on 21 May 2013
An External Quality Assurance (EQA) program in hematology is web-based and located on a cloud server. More...
It can be run from any computer without the need for software installation.

The program is online, which means that the quality organization can more easily collect and create a customized database of interesting patient cases. The program uses digital images of white and red cells in blood and other body fluids.

CellaVision (Lund, Sweden) has signed an agreement with Equalis (Uppsala, Sweden), a provider of external quality assessment for clinical laboratory tests. Equalis is investing in CellaVision's new proficiency testing program for the identification of cells in blood and other body fluids, CellaVision Proficiency Software. The order comprises a license for 350 users. During the year, the product will be introduced into Equalis' quality assurance scheme for Swedish clinical laboratories in Hematology.

When compared to the traditional testing methods which use blood smears on glass slides, this software is efficient, user friendly, and allows all participants to view and identify the same cells. This simplifies administration, performance, and monitoring of the test, as well as creating conditions for faster analysis and more accurate reporting.

"With CellaVision Proficiency Software, we reach out easily to our scheme participants in hematology and can offer them a digital quality control tool that creates conditions for increased knowledge and more standardized test results," said Gunnar Nordin, managing director and CMO at Equalis. "One of the great benefits of the program, in addition to allowing us to easily distribute, monitor, and follow up tests on-line, is that participants get instant feedback on their performance in form of valuable statistics. The program is both a testing tool and a source to increase knowledge."

CellaVision Proficiency Software is sold as an annual license directly by CellaVision. The program is available in two versions, the Enterprise Edition for external quality assessment organizations with up to 2000 users, and the Professional Edition for laboratories and universities with 10–100 users. The Professional Edition includes a customized web portal. More information can be found online (Please see Related Links below).

Equalis is a not-for-profit organization that provides external quality assessment of clinical laboratory investigations. It is accredited by Swedac as a provider of interlaboratory comparisons in laboratory medicine. Now Equalis will incorporate the CellaVision Proficiency Software in its quality assessment program for hematology analyses.

CellaVision is a medical technology company that develops and sells its own systems for routine analysis of blood and other body fluids in health care services. The products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals.

Related Links:

CellaVision
CellaVison Proficiency Software
Equalis



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automatic CLIA Analyzer
Shine i6000
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NeoGenomics selected Indica Labs’ HALO AP platform to eable its digital pathology operations through a scalable, cloud-based framework (Photo courtesy of Indica Labs)

Expanded Partnership Scales AI-Powered Digital Pathology for Oncology

Oncology diagnostics rely on pathology and biomarker information to guide personalized treatment. As computational pathology and artificial intelligence (AI) expand insights from tissue analysis, laboratories... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.